Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ Keratosis, Actinic
Keratosis, Actinic
20 registered clinical trials studyying Keratosis, Actinic.
Status
Trial
Sponsor
Phase
Completed
A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Kerato
NCT06135415
Almirall, S.A.
Phase 3
Completed
OCT and Invasion in Cutaneous Skin Lesions
NCT06014697
Maastricht University Medical Center
—
Active Not Recruiting
Microwave Treatment for Actinic Keratosis
NCT05636800
Blackwell Device Consulting
N/A
Active Not Recruiting
A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actini
NCT05387525
Almirall, S.A.
Phase 4
Completed
A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crus
NCT05356572
Mirka Ltd
N/A
Completed
A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic
NCT05279131
Almirall, S.A.
Phase 3
Completed
UV Sensor in Patients With Actinic Keratosis
NCT05481073
Almirall, S.A.
—
Completed
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT05260073
Almirall, S.A.
—
Completed
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of
NCT05060237
Biofrontera Bioscience GmbH
Phase 1
Terminated
A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochl
NCT04269395
Galderma R&D
Phase 3
Withdrawn
A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
NCT02813902
Massachusetts General Hospital
Phase 1
Completed
Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage
NCT03697590
Bispebjerg Hospital
Phase 4
Completed
Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS
NCT03076892
University Hospital, Lille
N/A
Completed
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
NCT02628236
DUSA Pharmaceuticals, Inc.
Phase 2
Completed
Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol
NCT02644187
Vastra Gotaland Region
N/A
Completed
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
NCT02281136
DUSA Pharmaceuticals, Inc.
Phase 2
Completed
The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
NCT02594644
University of California, Davis
N/A
Unknown
IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
NCT02281682
Maastricht University Medical Center
Phase 4
Terminated
Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy
NCT03076918
University Hospital, Lille
N/A
Completed
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
NCT01458587
DUSA Pharmaceuticals, Inc.
Phase 2